# Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease

> **NCT01438151** · NA · TERMINATED · sponsor: **Shradha Agarwal** · enrollment: 11 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Remicade

## Key facts

- **NCT ID:** NCT01438151
- **Lead sponsor:** Shradha Agarwal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-12
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** terminated due to poor enrollment
- **Last updated:** 2014-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438151, "Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01438151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*